Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2022

Open Access 01-12-2022 | Retraction Note

Retraction Note: MicroRNA-15b shuttled by bone marrow mesenchymal stem cell-derived extracellular vesicles binds to WWP1 and promotes osteogenic differentiation

Authors: Yanhong Li, Jing Wang, Yanchao Ma, Wenjia Du, Haijun Feng, Kai Feng, Guangjie Li, Shuanke Wang

Published in: Arthritis Research & Therapy | Issue 1/2022

Login to get access

Excerpt

Retraction Note: Arthritis Res Ther 22, 269 (2020) …
Metadata
Title
Retraction Note: MicroRNA-15b shuttled by bone marrow mesenchymal stem cell-derived extracellular vesicles binds to WWP1 and promotes osteogenic differentiation
Authors
Yanhong Li
Jing Wang
Yanchao Ma
Wenjia Du
Haijun Feng
Kai Feng
Guangjie Li
Shuanke Wang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2022
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-022-02950-3

Other articles of this Issue 1/2022

Arthritis Research & Therapy 1/2022 Go to the issue

Research article

Global burden of rheumatic heart disease: trends from 1990 to 2019

Research

Four emerging immune cellular blood phenotypes associated with disease duration and activity established in Psoriatic Arthritis

Research

Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study

Research

Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications

Research article

Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry

Correspondence

Comment on “The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis” by Yu et al.
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits